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Abstract: As the nervous system develops, connections between neurons must form to enable efficient
communication. This complex process of synaptic development requires the coordination of a series
of intricate mechanisms between partner neurons to ensure pre- and postsynaptic differentiation.
Many of these mechanisms employ transsynaptic signaling via essential secreted factors and cell
surface receptors to promote each step of synaptic development. One such cell surface receptor,
LRP4, has emerged as a synaptic organizer, playing a critical role in conveying extracellular signals to
initiate diverse intracellular events during development. To date, LRP4 is largely known for its role
in development of the mammalian neuromuscular junction, where it functions as a receptor for the
synaptogenic signal Agrin to regulate synapse development. Recently however, LRP4 has emerged
as a synapse organizer in the brain, where new functions for the protein continue to arise, adding
further complexity to its already versatile roles. Additional findings indicate that LRP4 plays a role
in disorders of the nervous system, including myasthenia gravis, amyotrophic lateral sclerosis, and
Alzheimer’s disease, demonstrating the need for further study to understand disease etiology. This
review will highlight our current knowledge of how LRP4 functions in the nervous system, focusing
on the diverse developmental roles and different modes this essential cell surface protein uses to
ensure the formation of robust synaptic connections.
Keywords: LRP4; Agrin; synaptogenesis; neuromuscular junction; brain; central nervous system;
peripheral nervous system; Drosophila
1. Introduction
To perform the complex computations that underlie cognition, behavior, and emo-
tion, neurons must communicate with each other in a reliable, but plastic, fashion. This
information transfer is mediated by synapses—essential, specialized sites of intercellular
communication in the nervous system. During development, these connections form
between pre- and postsynaptic cells through a series of intricate and intertwined steps,
ranging from recruitment of proteins that comprise neurotransmitter release sites and
receptors, to transcriptional changes and synapse-to-nucleus signaling that engage long-
lasting changes [1,2]. The success of each step is critical for the development of a functional
connection. To ensure this, each aspect of synaptic development is carefully dictated by
signaling molecules that coordinate development by triggering activation or deactivation of
pathways. These signals transpire between synaptic partners to ensure precise synchrony
across development. Oftentimes, a single protein regulates many downstream steps in this
process, leading to the concept of a “synaptic organizer”. These nexus points of cellular
signaling trigger events in multiple downstream pathways; as such, their perturbation
leads to widespread defects in development due to the disruption of a core component in
those multiple pathways. Such proteins use different mechanisms to initiate downstream
developmental events but often rely on a common principle wherein extracellular signals
between neurons initiate intracellular changes [3–5]. Consistent with this, cell surface
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receptors are well positioned to serve as these synaptic organizers: they can bind a lig-
and on the outside of the cell and then enact changes in multiple downstream signaling
pathways within the neuron [6]. In the last decade, LRP4, a member of the low-density
lipoprotein receptor family, has emerged as a synaptic organizer in the nervous system,
functioning in a range of cellular processes to signal between cells during development.
In the nervous system, LRP4 has been largely studied at peripheral synapses, where it is
critical for synapse formation but more recently emerged as a synaptic organizer at central
synapses, where its numerous roles remain incompletely understood.




Figure 1. Molecular structure of human LRP4. LRP4 is a single pass, type I transmembrane pro-
tein. The large extracellular region, capable of ligand-binding to Agrin, Wnt, and other proteins, 
contains LDL repeats (blue), EGF-like domains (pink), and β-propeller domains (green). The intra-
cellular portion is a comparatively shorter tail that contains an NPxY motif and a PDZ-binding 
motif, which are important for protein interactions and receptor endocytosis. While most of the 
extracellular portion is shared among species, other mammalian forms have an additional EGF-
like domain after the final β-propeller domain. On the intracellular side, mammalian forms of 
LRP4 share the NPxY and PDZ-binding motifs, though these are lacking in the Drosophila homo-
logue. 
2. LRP4 as a Critical Receptor for Agrin during NMJ Development 
Arguably the most well-understood role, to date, of LRP4 is as a synaptogenic mole-
cule at the mammalian NMJ. The NMJ is a highly specialized synapse where motor neu-
rons contact muscle fibers. There, signals from the presynaptic motor neuron are trans-
mitted to muscle via the neurotransmitter acetylcholine, which binds receptors on the 
postsynaptic muscle cell, triggering ionic influx, and resulting in contraction. The unique 
structure of the NMJ allows for fast, reliable neurotransmission to ensure each nerve im-
pulse results in muscle contraction. Acetylcholine receptors (AChRs) are anchored on the 
postsynaptic muscle cell membrane in highly concentrated clusters which correspond to 
presynaptic sites of acetylcholine release [34,35]. This clustering represents a key event in 
synaptogenesis and synaptic development at the mammalian NMJ. During development, 
before the muscle cell becomes innervated by a motor neuron, AChRs are pre-patterned 
in an evenly distributed manner along the center of the muscle fiber. Arrival of the motor 
axon initiates cellular changes in the muscle via secreted motor-neuron derived signaling 
molecules that instruct clustering and anchoring of postsynaptic AChRs, as well as other 
aspects of postsynaptic differentiation, including transcriptional changes [36,37]. One 
such secreted signaling molecule is the proteoglycan Agrin, which is released from the 
motor neuron and can induce AChR clustering [38]. Agrin signals postsynaptic differen-
tiation via activation of a postsynaptic receptor tyrosine kinase, MuSK (Muscle Specific 
Kinase) [39–42]. Though Agrin and MuSK were established as major synaptogenic mole-
cules functioning in the same pathway, a direct interaction between them could not be 
shown [41], leading to the hypothesis that a third, yet-unidentified, molecule connected 
the two and serving as an Agrin receptor [41]. LRP4 became that likely candidate follow-
ing the discovery in 2006 that it is expressed in muscles during development and its loss-
of-function phenotypes mirror those of MuSK mutants: lrp4 mutant muscles lack AChR 
clusters, and postsynaptic proteins including Rapsyn and Utrophin do not localize 
Figure 1. Molecular structure of human LRP4. LRP4 is a single pass, type I transmembrane protein.
The large extracellular region, capable of ligand-binding to Agrin, Wnt, and other proteins, contains
LDL repeats (blue), EGF-like domains (pink), and β-propeller domains (green). The intracellular
portion is a comparatively shorter tail that contains an NPxY motif and a PDZ-binding motif, which
are important for protein interactions and receptor endocytosis. While most of the extracellular
portion is shared among species, other ma malian forms have an dditional EGF-like d ain after
the final β-propeller domain. On the i tracellular side, mamm lian forms of LRP4 share the NPxY
and PDZ-binding motifs, though these are lacking in the Drosophila homologue.
Following the first identification of LRP4 in 1998 [7], our understanding of its function
has grown to encompass a wide range of cellular events, primarily during development.
LRP4 is a single pass, type I transmembrane protein, and a member of the low-density
lipoprotein-related receptor (LRP) family. It functions as a receptor for various ligands,
including Wnt and Agrin [8]. Like other LRPs, LRP4 contains multiple LDLa repeats, as
well as EGF-like and β-propeller domains, which are important for ligand binding to the
extracellular domain of the protein (Figure 1). LRP4 also shares intracellular sequence mo-
tifs with other LRPs, including an NPxY motif, that are important for receptor endocytosis,
trafficking, and intracellular signaling [9,10]. Biologically, LRP4 is involved in a myriad
of processes, including limb development [11,12], craniofacial organogenesis [13,14], os-
teogenesis [15], kidney development [16], and neurodevelopment [17]. Loss of LRP4 in
mice results in death due to paralysis, likely caused by a failure of the neuromuscular
junction (NMJ) to develop [17], thereby preventing communication between motor neurons
and muscle cells. This suggests that its role in synapse formation and organization is
paramount for survival. Since its initial implication in nervous system development, work
from a number of groups showed that LRP4 promotes neuromuscular junction forma-
tion and maintenance [17–20], peripheral nerve regeneration [21], central nervous system
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development [22–24], cognitive function and plasticity [25,26], and adult hippocampal
neurogenesis [27] across different organisms and in different model systems. This indicates
that these critical and diverse roles in neurodevelopment may be evolutionarily conserved.
Further underscoring its importance in nervous system function and highlighting a po-
tential link to human disease, the loss of LRP4 is linked to multiple neurodegenerative
diseases including myasthenia gravis [28–30], amyotrophic lateral sclerosis (ALS) [31],
and Alzheimer’s disease [32,33]. To begin to understand these roles, we will consider
them in the context of three major categorizations, into which the functions for each of
these roles can be placed: (1) whether LRP4 functions pre- or postsynaptically, (2) whether
LRP4 functions in an Agrin-dependent or Agrin-independent manner, and (3) whether
LRP4 functions in a cell-autonomous or non-cell autonomous fashion. In considering the
diverse roles for LRP4, these categories (though neither essentially mutually exclusive of
one another nor exhaustive) offer a useful conceptual framework to dissect our current
knowledge of the different mechanisms of LRP4 function. Further, as new findings begin
to elucidate the mechanisms of LRP4 function in central synapse development, exciting
questions have emerged. How do these categories factor into LRP4 function at peripheral
and central synapses? How are perturbations of LRP4 linked to human disease? While
our understanding of these roles for LRP4 is ever growing, ongoing studies have provided
tantalizing evidence for LRP4 as a new player in both development and disease at a variety
of synapses.
2. LRP4 as a Critical Receptor for Agrin during NMJ Development
Arguably the most well-understood role, to date, of LRP4 is as a synaptogenic molecule
at the mammalian NMJ. The NMJ is a highly specialized synapse where motor neurons
contact muscle fibers. There, signals from the presynaptic motor neuron are transmitted to
muscle via the neurotransmitter acetylcholine, which binds receptors on the postsynaptic
muscle cell, triggering ionic influx, and resulting in contraction. The unique structure of
the NMJ allows for fast, reliable neurotransmission to ensure each nerve impulse results
in muscle contraction. Acetylcholine receptors (AChRs) are anchored on the postsynaptic
muscle cell membrane in highly concentrated clusters which correspond to presynaptic sites
of acetylcholine release [34,35]. This clustering represents a key event in synaptogenesis and
synaptic development at the mammalian NMJ. During development, before the muscle cell
becomes innervated by a motor neuron, AChRs are pre-patterned in an evenly distributed
manner along the center of the muscle fiber. Arrival of the motor axon initiates cellular
changes in the muscle via secreted motor-neuron derived signaling molecules that instruct
clustering and anchoring of postsynaptic AChRs, as well as other aspects of postsynaptic
differentiation, including transcriptional changes [36,37]. One such secreted signaling
molecule is the proteoglycan Agrin, which is released from the motor neuron and can
induce AChR clustering [38]. Agrin signals postsynaptic differentiation via activation of
a postsynaptic receptor tyrosine kinase, MuSK (Muscle Specific Kinase) [39–42]. Though
Agrin and MuSK were established as major synaptogenic molecules functioning in the
same pathway, a direct interaction between them could not be shown [41], leading to the
hypothesis that a third, yet-unidentified, molecule connected the two and serving as an
Agrin receptor [41]. LRP4 became that likely candidate following the discovery in 2006
that it is expressed in muscles during development and its loss-of-function phenotypes
mirror those of MuSK mutants: lrp4 mutant muscles lack AChR clusters, and postsynaptic
proteins including Rapsyn and Utrophin do not localize properly [17]. Furthermore, AChR
clusters fail to form in lrp4 mutant myotubes, either spontaneously or in response to Agrin
stimulation [17]. Landmark work by the Mei and Burden labs subsequently showed that
LRP4 can bind both Agrin and MuSK [18,19]. In this role, postsynaptic LRP4 in the muscle
binds Agrin via its N-terminus, forming a tetrameric complex (two molecules of Agrin
and two molecules of LRP4) and promoting the subsequent interaction between LRP4 and
MuSK [43,44]. The ensuing downstream molecular cascade results in the dimerization
and phosphorylation of MuSK [35,45] and subsequent phosphorylation of Dok7, which
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leads to transcriptional changes and clustering of postsynaptic proteins [46,47]. AChR
clustering occurs through interaction with Rapsyn, a peripheral membrane protein which
binds AChRs [48]. (Figure 2). Subsequent work identified additional regulators of LRP4,
including Mesdc2 and CTGF, which promote LRP4 function through increased surface
expression [49] and enhanced MuSK binding [50]. In this most well-understood role of
LRP4, its function can be classified as postsynaptic, Agrin-dependent, and cell autonomous,
according to the abovementioned categories. The discovery of this critical role of LRP4
established the missing link of mammalian NMJ formation and opened a new field of
study to understand the downstream mechanisms of LRP4 function, the additional roles
LRP4 engages in different processes at peripheral and central synapses, and the current
categories by which we can begin to group those roles.
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Figure 2. LRP4 is essential for postsynaptic differentiation at the mammalian NMJ. In its most
well-known role at the mammalian NMJ, LRP4 serves as the receptor of Agrin. Agrin is a secreted
proteoglycan, derived from the motor neuron, that traverses the synaptic cleft before binding to post-
synaptic LRP4. Binding of Agrin to LRP4 induces the formation of a tetrameric complex (containing
two molecules of Agrin and two molecules of LRP4) that promotes association with and activation
of the receptor tyrosine kinase MuSK. Dimerization of MuSK subsequently signal downstream
thr ugh Dok7 to instr ct aspects of postsynaptic differentiation, including the anchoring of proteins
like AChR via interaction with Rapsyn, and transcription of genes encoding syna tic pr teins at
subsynaptic nucl .
3. Further Roles for LRP4 in the Peripheral Nervous System
The discovery of LRP4 as the receptor of Agrin to instruct postsynaptic differentiation
via MuSK established the basis of our understanding of LRP4 function in the nervous
system. However, importantly, it raised the tantalizing possibility that LRP4 could have
additional roles at synapses. While postsynaptic NMJ differentiation remains its most
studied role to date, further work identified other, earlier, mechanisms of LRP4 function at
the NMJ (Figure 3). These roles contrast the well-known function of LRP4 discussed above,
and further highlight the different categories of LRP4 function: throughout NMJ develop-
ment and in contrast to its role in synaptic clustering as the Agrin receptor, LRP4 can also
function at the presynapse, independently of Agrin, and in a non-cell autonomous manner.
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the motor axon (A), LRP4 is required for pre-patterning of acetylcholine receptors in the prospective synaptic region (role 1).
Upon arrival of the motor axon, LRP4 is required as a stop signal for the growth cone to arrest further travel along the
uscle fiber (role 2). This role is important for the initiation of adhesive contact between the motoneuron and the muscle.
Once the growth cone has transitioned o a growing synaptic contact, LRP4 then instructs pr synaptic differentiation
(B, role 3), likely by the cleaved extra llular domain of LRP4 binding a yet-unknown receptor on motor axons to signal
downstream clustering of vesicle and active zone proteins. LRP4 also signals postsynaptic differentiation (C, role 4) by
binding Agrin and stimulating MuSK activation (discussed above; see Figure 2). For simplicity, this diagram represents a
dimerized LRP4-agrin interaction (as shown in Figure 2) and represented in [44].
Early in development, before its rol in postsynaptic differentiation, LRP4 is important
for initial steps of synapse d lopment. Prior o motor euron arriv l, LRP4 is required to
instruct cellular events; lrp4 mutant mice do not xhibit early cell-autonomous clustering of
AChR receptors in the pro pectiv synap ic region [17]. This indicates tha LRP4 functions
at the postsynapse to instruct pre-patterning AChR in the muscle (Figure 3A). The
mechanism of this earlier function of LRP4 differs from its late role in AChR cluster g in
that it is does not r qu re Agrin binding but requires MuSK [51]. Thus the cas of this
pre-pattern g role for LRP4, it functions at the postsynapse, independ ntly of Agrin, and
in a cell-autonomous manner. Beyond this postsynaptic role in th initial pre-patterning
of AChRs, LRP4 plays additional roles in early NMJ development, but at the presynaps .
In mice, loss of LRP4 results in excessive growth of motor axons al g the muscle fiber,
suggesting that LRP4 is required to signal the growth cone to stop and form adhesive
connections [17,52,53] (Figure 3A). The absence of such a stop signal results in overgrowth
of the motor neuron. While the exact mechanism of this role is unknown, it may be linked
to the role of LRP4 in pre-patterning, as pre-patterned AChRs may serve as an indicator
of the prospective synaptic region. In contrast to LRP4’s role in pre-patterning, however,
this role as a stop signal is likely the result of a muscle to motor neuron signal. Specific
loss of presynaptic LRP4 from the motor neuron does not produce an axonal overgrowth
phenotype, suggesting that cell-autonomous LRP4 is not required for this context [35].
This indicates a more likely postsynaptic, Agrin-independent, and non-cell autonomous
function. When juxtaposed, these roles highlight the intriguing complexity and importance
of LRP4 function in utilizing different strategies to control temporally linked steps of
neurodevelopment.
Once a connection is established, LRP4 continues to play a role in motor neuron
development. In the absence of LRP4, motor neurons are unable to cluster active zone and
vesicle proteins, indicating that LRP4 also serves as an early signal to induce presynaptic
differentiation (Figure 3B) [17,52]. Intriguingly, though, these severe presynaptic effects are
mediated by a non-cell autonomous mechanism of muscle-derived LRP4 [52], which re-
quires that LRP4 enact these cellular events from across the synapse. Thus, LRP4 functions
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in trans as a retrograde signal to instruct presynaptic differentiation [54]. Furthermore,
it functions independently of Agrin binding and MuSK activation, likely by interacting
with a yet-unidentified receptor on motor axons [52]. Thus, while postsynaptic LRP4 is
required, it does so by acting directly on the presynapse. This retrograde role for LRP4 is
further supported by evidence that LRP4 is cleaved at the NMJ, its extracellular domain
is sufficient to instruct NMJ formation, and it does not need to be anchored in the cell
membrane to function [35,55–57]. The cleaved extracellular region of LRP4 thus functions
as a ligand to instruct downstream recruitment of active zone and vesicle proteins [52].
The proteolytic mechanism by which LRP4 is cleaved in order to function as a retrograde
signal is currently unknown, though it likely occurs via matrix metalloproteinase (MMP)
activity [54]. Recent work at the Xenopus NMJ has identified a potential proteolytic mecha-
nism. At this synapse, MT1-MMP is required for Agrin-LRP4 signaling, and cleavage of
LRP4 by MT1-MMP is sufficient to produce the diffusible extracellular fragment of LRP4 to
signal presynaptically [57]. Whether this mechanism extends to other species and at other
synapses, however, remains unknown. In all, though these roles can be categorized into
the three broad classifications as noted above; this particular example further highlights
the complexity and versatility of LRP4 function. Furthermore, it presents a fascinating op-
portunity for future study to determine the mechanism by which retrograde LRP4 signals
presynaptic differentiation.
Beyond the non-cell autonomous function of muscle-derived LRP4 on the motor axon,
LRP4 derived from the presynaptic motor neuron itself can also function cell autonomously.
Though this pool of LRP4 is not essential for survival, it can promote development [54].
Genetic studies that removed LRP4 function specifically from one tissue, either muscles
or motor neurons, allowed for the separation of these two pools and an assessment of
how each contributes to development [54]. Interestingly, despite its importance as a
postsynaptic molecule, loss of mouse lrp4 from muscle alone results in viable pups with
underdeveloped NMJs and immature AChR clusters that have formed but not achieved
their fully developed adult form. However, loss of lrp4 in both muscle and neuron results
in perinatal death and NMJs resembling whole animal mutants, suggesting a role for
neuronal LRP4 [54] or at least the combination of neuronal and muscle LRP4 in ensuring
viability. Motor neuron-specific lrp4 mutant mice are functionally similar to control mice,
suggesting that neuronal LRP4 may play a role in development, but likely within the
abovementioned combination or via a non-essential mechanism. Thus, non-muscle LRP4,
likely from the motor neuron, may promote rudimentary AChR clustering in the absence
of muscle LRP4, resulting in the immature AChR clusters observed in the muscle alone
knockout [54]. This further suggests an intricate interplay between the two pools of LRP4
and highlights an interesting counterposition to the previous example: here, LRP4 would
be presynaptically derived and function non-cell autonomously at the postsynapse initiate
AChR clustering. How pre-patterning might occur in the absence of muscle LRP4 and prior
to arrival of the motor neuron, though, remains unclear. Finally, despite working in trans,
LRP4 function here is likely Agrin-dependent [54]. It is important to note that this may not
serve as the only role for LRP4 in the motoneuron; a more thorough understanding of the
phenotypic consequences of motoneuron lrp4 loss will be important to determine if other,
cell-autonomous, presynaptic functions exist. Regardless, these elements highlight a deep
complexity to LRP4 with multiple, nuanced roles at the synapse.
While many of these functions of LRP4 require its activity as an Agrin receptor, a
growing body of work in recent years highlighted the Agrin-independent roles of LRP4
function. Outside of the nervous system, LRP4 likely functions entirely independent of
Agrin. Mechanistically, how might this occur? One possibility, drawing from developmen-
tal pathways, is that LRP4 functions in Wnt signaling pathways [15,58,59]. In bone and
kidney, LRP4 works with Wnt ligands to promote development [13,15,16]. In these contexts,
LRP4 is a Wnt signaling antagonist, either by binding Wnt directly, or by interacting with a
Wnt inhibitor [15,58,59]. In the nervous system, Wnt proteins are essential for CNS synapse
formation [60,61], AChR clustering at the vertebrate NMJ [62,63], and NMJ formation in
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Drosophila and C. elegans [64–66]. Consistent with these similarities, there is remarkable
interplay between LRP4 and Wnts in the nervous system, particularly in AChR clustering
in both mice and zebrafish [62,67,68]. At the mammalian NMJ, Wnts have complex and
diverse roles in AChR clustering [67,69]. Two Wnts in particular, Wnt9a and Wnt11, in-
duce AChR clustering, and this role is dependent on LRP4 and MuSK, but independent
of Agrin [62]. This suggests that Agrin and Wnt function in distinct, parallel pathways
to instruct clustering [62,68]. Whether LRP4 serves as a Wnt receptor here is unknown,
however, though LRP4 can directly interact with Wnt9a and Wnt11 [62]. Furthermore,
other Wnts can inhibit Agrin-induced AChR clustering, indicating crosstalk between Wnt
and Agrin pathways, though it is unclear whether LRP4 is involved in this inhibition [67].
Due to these interesting intersections, the interplay of LRP4 and Wnt signaling, and indeed,
the mechanistic basis for Agrin-dependent vs. Agrin-independent LRP4 function is an
intriguing avenue for future investigations.
Finally, LRP4 continues to function after synapse formation at the NMJ, with a critical
role in synaptic maintenance. As whole-animal mutation of lrp4 results in neonatal lethal-
ity [17], understanding its role in adulthood has not been trivial. Conditional knockout of
LRP4 in muscle during adulthood, however, revealed critical roles in NMJ maintenance:
loss of LRP4 in adulthood leads to fragmentation of AChR clusters, reduced neurotrans-
mission, and decreased muscle strength [20]. This loss of LRP4 in the adult NMJ results
in a reduction in synaptic Agrin levels, indicating that LRP4 may be required to stabilize
Agrin [20]. Thus, LRP4 is essential to maintain the structure and function of the NMJ after
development. These post-developmental roles for LRP4 stretch beyond NMJ maintenance
as well. In zebrafish, LRP4 functions in the peripheral nervous system in response to injury
by coordinating axon-glia interactions to ensure regrowth of follower axons [21] and does
so independently of Agrin and MuSK, via an unknown mechanism [21]. Our understand-
ing of these roles remains incomplete: they highlight the differences in Agrin-requirement
in adulthood, but how these roles (or potential additional roles) function with respect to pre-
versus postsynaptic or regarding cell autonomy, remains a topic for future investigation.
Regardless, these roles indicate the importance of LRP4 to the nervous system throughout
life, highlight the complexity in its myriad of roles, and raise the likelihood that it is a
powerful substrate for future study for its therapeutic potential, as many neurological
diseases arise during development [70].
4. LRP4: An Emerging Player in CNS Development
In recent years, a growing body of literature has expanded LRP4 function beyond the
peripheral nervous system and into the central nervous system, both in development and
adulthood. These studies have raised new questions about the downstream mechanisms of
LRP4 and whether it uses similar mechanisms as peripheral synaptogenesis to instruct cen-
tral synaptogenesis. Intriguingly, much like its peripheral roles, the same major categories
(pre- vs. postsynaptic; Agrin-dependent vs. independent; cell autonomous vs. non-cell
autonomous) continue to emerge as classifiers for LRP4 in the central nervous system in
terms of their mechanistic functions.
In the CNS, cell-autonomous developmental roles for LRP4 begin even before synapses
form, specifically in hippocampal neurogenesis. In the adult hippocampus, neurogenesis
increases by an unknown mechanism in response to an enriched environment; this may al-
low the brain to adapt to environmental changes [71]. New neurons integrate their synaptic
connections into existing networks [72,73]. In mice, loss of LRP4 in neural stem/progenitor
cells (NSPCs) prevents this neurogenesis after exposure to an enriched environment. In
this role, LRP4 functions cell-autonomously in NSPCs in an Agrin-dependent manner [27].
The third category, that of pre- vs. postsynaptic, cannot be applied as these neurons have
not yet formed connections. Unlike predominant examples from the NMJ, where LRP4
signals through MuSK, this pathway utilizes a different kinase, Ror2, which is closely
related to MuSK [74] and likely functions in a similar manner. This unexpected role for
LRP4 and Agrin in the brain raises interesting questions about how LRP4 functions outside
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of synapse development [27] while highlighting similar mechanistic options for LRP4 as in
the periphery.
The most studied roles of LRP4 in the CNS, however, mirror those most-studied
in the periphery: the function of LRP4 in synaptogenesis. In the CNS, this was first
uncovered in the Drosophila olfactory system [22]. The Drosophila LRP4 homologue shares
61% identity in its extracellular region with mammalian LRP4 [22], suggesting from a
sequence similarity standpoint that the two could have similar functions in nervous system
development. Indeed, in the Drosophila olfactory system, LRP4 is expressed presynaptically
(Figure 4A) and instructs active zone formation in excitatory, but not inhibitory, neurons:
loss of presynaptic lrp4 results in fewer active zones and postsynaptic receptor clusters,
as well as disruption of active zone ultrastructure. Loss of lrp4 also leads to behavioral
consequences—flies lacking LRP4 in olfactory neurons exhibit a complete loss of olfactory
attraction behavior, corresponding to synaptic defects. Just as loss of lrp4 decreases active
zone number, overexpression leads to an increase in active zone number, demonstrating
an instructive role for LRP4 in mediating synaptic contacts [22]. Drosophila lack clear
homologues for both Agrin and MuSK [75], so these functions for Drosophila LRP4 must
occur through a different mechanism than at the mammalian NMJ, highlighting an Agrin-
independent aspect of this novel presynaptic function for LRP4. This raises the hypothesis
that LRP4 may be the more evolutionarily ancient player in the Agrin-MuSK pathway
during synapse development. The mechanism by which LRP4 functions in olfactory
receptor neurons is incompletely understood, but it likely functions at least partly with
the serine arginine protein kinase SRPK79D to ensure proper active zone number [22].
lrp4 mutants exhibit an aberrant accumulation of the active zone protein Bruchpilot (Brp)
in transverse nerves, which is reminiscent of the srpk79D mutant phenotypes [76,77]. It
remains unknown whether this accumulation of Brp in the axon corresponds to the decrease
in the number of synaptic active zones. Loss of srpk79D mirrors additional lrp4 mutant
phenotypes, and overexpression of SRPK79D is sufficient to rescue both synapse number
and behavioral defects in the absence of LRP4. The downstream requirement for SRPK79D
highlights a common theme of LRP4 function: many pathways function via a downstream
kinase, whether MuSK, Ror2, or SRPK79D. In all, this role for Drosophila LRP4 in central
synaptogenesis is particularly interesting for its contrast to LRP4 function at the mammalian
NMJ; LRP4 functions presynaptically, cell autonomously, and independently of Agrin (and
MuSK). Thus, despite divergent mechanisms, LRP4 function can still be categorized into
these broad classifiers of function. Beyond this, Drosophila may provide further insights into
additional, presynaptic and/or Agrin-independent roles for LRP4 at mammalian synapses.
Whether LRP4 also has non-cell autonomous roles in Drosophila, like in mammals, remains
unknown. Emerging work in Drosophila indicates another central synapse role for LRP4,
in synaptic partner choice in the visual system. This further demonstrates its widespread
importance in the developing brain and suggests that the roles of LRP4 in the olfactory
system may also apply to other brain regions (though the nature of its cell autonomy or
non-autonomy is currently unknown). Here, LRP4 is required for proper targeting of
photoreceptor axons and may undergo regulation by another LDL family member, lost and
found. Perturbation of lrp4 results in defects in target selection, but whether LRP4 is also
involved in other aspects of visual system development, including synapse formation and
function, remains unknown [78]. As LRP4 is expressed widely throughout the Drosophila
brain [22] and the mammalian literature suggests diverse function, understanding how
LRP4 promotes Drosophila synaptic development function may provide further insights
into its versatile roles. For instance, whether Drosophila LRP4 also functions at the NMJ
or in glial cells to regulate synaptic biology or neuronal development is unknown and
remains an active topic of investigation.
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development in both invertebrate and vertebrate central nervous systems. In Drosophila (A), which
lack both Agrin and MuSK homologues, LRP4 functions presynaptically in the olfactory system
to instruct active zone formation. The ligand of LRP4 (and its exact source) remain unknown in
this model. Two potential sources, a postsynaptic partner or glia, are indicated in this diagram. To
instruct presynaptic changes, LRP4 functions thro gh the downstream kinase, SRPK79D. In mouse
cortical and hippocampal neuro s (B), LRP4 functions in a simila nner to regulate synaptic
density. It is unknown whether LRP4 functions primarily at the pre- or postsynapse; for the purposes
of this model, it is shown as postsynaptic but could also function presynaptically. In these contexts,
LRP4 induces presynaptic differentiation via an Agrin-dependent mechanism and regulates dendrite
morphogenesis through a MuSK-dependent mechanism. In addition, LRP4 has important glial roles
(in regulating growth and neurotransmission) and may be functioning in this role or in currently
undiscovered functions.
Beyond Drosophila, there is also a conserved requirement for LRP4 in regulating cen-
tral synapse formation in the mammalian brain (Figure 4B). In cortical and hippocampal
neurons, the loss of LRP4 results in decreased density of both excitatory and inhibitory
synapses, along with fewer, but longer, primary dendrites [23,24]. Consistently, over-
expression of LRP4 increases synaptic density and results in shorter, more numerous
dendrites [23]. Here, LRP4 is enriched in both pre- and postsynaptic membranes, suggest-
ing both pre- and postsynaptic roles in the brain [25], though it is not yet known which
of these pools instructs which aspect or aspects of synapse development (and thus, how
this role is classified). At mammalian central synapses (as at the NMJ), LRP4 functions
in an Agrin-dependent manner: loss of lrp4 blocks Agrin-induced increases in synapse
number [24,79]. The involvement of MuSK, however, is less well understood. MuSK is
required for proper den ritic branching in the brain, but not for normal synaptic den-
sity [24], suggesting that LRP4 could use both Agrin-dependent/MuSK-dependent and
Agrin-dependent/MuSK-independent pathways. Interestingly, evidence from synaptic
tracing experiments suggests that perturbation of lrp4 may lead to both ostsynaptic and
presynaptic def cts, as knockdown of lrp4 in ne rons resulted in fewer sy aptic part-
ners [23]. Thus, like at the NMJ, LRP4 may function in multiple ways to instruct pre- and
postsynaptic developm nt, highlighting mechanistic si ilarity between peripheral and
central sy tems s well s th cell-auton my v . on cell-autonomy comparison. The down-
s ream mechanisms that propagate LRP4-i volved signaling, however, ar unclear. On
sp culation is that LRP4 regulates the cytosk leton, as this c uld account for defects in both
dev lopment of presynaptic t rminals an dendrite morphogenesis. This s also supported
by evidence that LRP4 overexpression decreases the mobility of dendrite terminals [23].
Insights from Drosophila may also inform further work in the mammalian brain; both
systems exhibit similar synaptic phenotypes following loss of lrp4. Furthermore, serine
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arginine protein kinases, which likely interact with LRP4 in the fly brain, are conserved in
mammals [22,80] and might also function with LRP4 in the mammalian brain. However, it
is important to note that there are critical differences between LRP4 in the fly brain versus
the mammalian brain in its Agrin-dependence and the synaptic specificity of the signaling
(excitatory vs. inhibitory). A deeper understanding of the mechanisms that underlie both
evolutionary realms of LRP4 function is an exciting area for future study and will likely
yield fascinating insight into brain development.
Synaptic roles in the brain for LRP4 may also persist into adulthood, much like in
the periphery. LRP4 is expressed robustly in the hippocampus, olfactory bulb, cerebellum,
and cerebral cortex [81,82]. In mice, loss of lrp4 in all tissues except skeletal muscle results
in defects in cognition and synaptic plasticity [25]. In the absence of LRP4, CA1 neurons
of the hippocampus have decreased spine density, and exhibit corresponding defects in
synaptic transmission and postsynaptic integration [25,26]. Currently, the underlying
etiology of these defects is unknown. CNS LRP4 may further function during adulthood
in synaptic maintenance. At the NMJ, such a role was determined using conditional
removal of lrp4 after the events of development and during adulthood to distinguish
between developmental and maintenance roles [20]. The equivalent experiments in the
CNS, however, have not yet been performed to assess cognition and plasticity and remain
an area for future study. As global knockout of lrp4 is lethal, conditional approaches have
been used to study brain function in adulthood: by restoring LRP4 expression in muscle [25]
of otherwise null lrp4 mutants, adult mice that lack lrp4 only in the CNS can be examined.
However, these experiments have also not assessed whether CNS LRP4 is required for
development or maintenance. Since neurodevelopmental disorders can arise when early
events of synapse formation fail to occur, or occur incorrectly [83], a developmental defect
remains a possible explanation. Recent work on glial LRP4, however, poses an alternative
hypothesis. LRP4 is expressed in astrocytes and modulates glutamatergic transmission in
hippocampal neurons by regulating ATP release. This effect is mediated by Agrin, though
the requirement for MuSK is unknown [84]. In addition, astrocytic LRP4 also has a role in
promoting dendrite arborization in neurons [85]. As such, disruption of glial LRP4 may
manifest as defects in cognitive function and synaptic plasticity [25]. These interesting new
findings on the role of astrocytic LRP4 present further exciting opportunities to study its
glial roles, which likely have widespread importance throughout the brain.
Taken together, the current state of the field highlights widespread and important roles
for LRP4 in the central nervous system ranging from neurogenesis, to synapse formation,
and even cognition. In many ways, these central roles of LRP4 mirror those of the NMJ,
especially in the context of their classification into pre- vs. postsynaptic mechanisms,
Agrin-dependent vs. Agrin-independent mechanisms, and cell autonomous vs. non-cell
autonomous mechanisms. However, beyond this, LRP4 has important, emerging roles in
glia as motivation for future study. While further investigation is needed to identify the
precise and versatile mechanisms by which LRP4 instructs these processes, its importance
in the brain is increasingly apparent.
5. An Evolutionarily Conserved Role for LRP4 in the Nervous System?
How synapses evolved from simple groupings of proteins in early prokaryotes to
the elegant, complex structures that underlie the complexity of the human brain remains
a tremendous unanswered question. Synaptic proteins exhibit a remarkable degree of
conservation across eukaryote species [86,87] and a number of mechanisms that instruct
synapse development are conserved [88,89] in evolutionarily distant systems. Studies of
LRP4 across species and systems present an opportunity to consider the evolutionary past
of LRP4, which can provide insight into its roles in the nervous system. First, how did
LRP4 evolve as a critical element of neurodevelopment? The LDL-receptor genes are an
evolutionarily ancient family that appear with the first multicellular organisms [90]. LRP4
is likely a more recent member of this family. Organisms including C. elegans have LRP
homologues that more closely resemble LRP1 and LRP2, but no explicit homologue of LRP4.
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Protein BLAST reveals homologues of LRP4 in more complex invertebrates, including
mollusks (such as Aplysia californica and Octopus bimaculoides), arthropods, and echinoderms
(which all largely resemble Drosophila LRP4) [75]. The Drosophila homologue in turn, shares
sequence homology with the extracellular portion of mammalian LRP4, but lacks the same
intracellular motifs [8,22] (Figure 5). Despite these differences, LRP4 functions in both
vertebrate and invertebrate nervous systems at central and peripheral synapses. Across
these species, LRP4 signals aspects of synapse development, albeit in various ways. This
indicates the evolutionary importance of the receptor, but how did its roles change during
evolution? In Drosophila, the LRP4 protein localizes predominantly presynaptically, in
contrast to mammals where it is predominantly postsynaptic [81]. This demonstrates
how one classifier of LRP4 function, its expression at the synapse, emerged over the
course of evolution. Further, in mammals, LRP4 functions in both peripheral and central
synaptogenesis via an Agrin-dependent mechanism. Interestingly, the Drosophila genome
does not contain obvious homologues to either Agrin or MuSK, suggesting that the Agrin-
dependent functions of LRP4 also arose with evolution of a more complex nervous system.
Yet, LRP4 shares a similar mechanism in flies in that it signals through a downstream kinase.
This likely indicates that the mechanism of LRP4 function shifted over time but retained
certain tenets of function. These considerations also raise interesting questions of whether
mammalian LRP4 has retained some of its more ancient roles, including presynaptic roles
in development, and perhaps signaling via a serine arginine protein kinase.
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Additional roles for LRP4 outside the nervous system may provide further insight
into its evolutionarily conservation. LRP4 has conserved roles in regulating Wnt signaling
throughout the body [15,58,59], which have also been shown in the nervous system and
further highlight Agrin-independent functions. Wnts are essential for synapse formation,
brain development, and organization [60,61,94]. These Wnt dependent pathways may
be more ancient, as they have been noted in invertebrates [95], while Agrin-dependent
synaptogenic pathways have not [96]. This may also suggest that the roles of LRP4
outside the nervous system, where it functions with Wnt signaling, are older than the
Agrin/MuSK-dependent pathway. Work on zebrafish NMJ development highlighted
divergent mechanisms for Wnt, LRP4, and MuSK pathways [68]. Like the mammalian NMJ,
the zebrafish NMJ exhibits pre-patterning of AChRs, but zebrafish LRP4 is not required
for AChR pre-patterning. However, zebrafish do require LRP4, Agrin, and MuSK for
synapse formation [68]. MuSK shares a similar cysteine rich domain with the Wnt receptor
Frizzled [74,97], suggesting that MuSK may also serve as a Wnt receptor, potentially in this
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role. The conservation of some, but not all, of these pathways raises intriguing questions
about the evolutionary history of LRP4. As LRP4 is expressed in central nervous system
synapses and has been implicated in CNS synapse formation, it remains an interesting and
open question whether CNS Wnt-dependent synapse formation requires LRP4, perhaps
similar to the role of LRP4 in Wnt-induced AChR clustering at the NMJ [62].
6. From Development to Disease
Underscoring the importance of synaptic connections to all elements of neuronal
function, the loss or mutation of genes that encode synaptic proteins are implicated in
a range of neurodevelopmental, neurological, and neurodegenerative disorders [98,99].
These disorders can aggregately be classified as synaptopathies, where genetic mutations
in or affecting synaptic proteins cause severe neurological and developmental disorders.
Often, disruption of a single aspect of the complex synaptic machinery is sufficient to cause
widespread changes in the brain, leading to disease [83]. Given the essential role for LRP4
in proper nervous system development and mature function, it is reasonable to hypothesize
that the loss or perturbation of LRP4 may underlie some of these synaptopathies. Consistent
with this hypothesis and given its well-known roles in the peripheral nervous system and
NMJ function, recent work implicated LRP4 in disorders of the motor unit, specifically
myasthenia gravis (MG), congenital myasthenic syndrome (CMS), and amyotrophic lateral
sclerosis (ALS).
Motor disorders often stem from mechanisms that result in impaired NMJ function
or the breakdown of essential components that contribute to the normal function of the
NMJ. Myasthenia gravis (MG) is an immune disorder where the body produces antibodies
against proteins required for NMJ function, resulting in muscle weakness [100]. Often,
these antibodies are against the AChR or MuSK, and loss of these proteins results in frag-
mentation of the NMJ [100]. More recent work implicated LRP4 as an additional player in
MG pathology; MG patients that displayed symptoms consistent with the motor disorder,
but were double seronegative against MuSK and AChR, instead had autoantibodies against
LRP4 [28,101]. Experimentally, mice immunized with anti-LRP4 antibodies exhibited
MG-associated symptoms including muscle weakness, as well as fragmented NMJs [29],
suggesting a causative relationship between the loss of LRP4 and MG. Analogous symp-
toms also occur in congenital myasthenic syndromes (CMS), which are caused by mutations
in genes important for NMJ function or maintenance [102]. LRP4 is implicated as a CMS
disease gene, but unlike MG, this is likely due to direct mutations in the lrp4 gene (and
not auto-immune targeting of the LRP4 protein). In CMS patient populations, two lrp4
mutations were identified which disrupt binding of LRP4 to Agrin and MuSK [103]. Thus,
LRP4 is implicated in two similar motor disorders, though via different mechanisms, both
resulting in reduced NMJ function. It remains unclear, though, how the different categories
of LRP4 mechanistic function interact with their potential roles in motor disorders like
MG. This will remain an interesting mechanistic question for future study. Mutation of
LRP4 in humans, though, does not always affect synapse development. Patients with
Cenani-Lenz syndrome, an autosomal recessive disorder which results in syndactyly and
oligodactyly and is caused by homozygous, mutation of LRP4, have seemingly normal
NMJs, despite loss of LRP4 function [16]. One explanation for this is compensation by
LRP10, which is similar to LRP4 and may have resulted from a recent gene duplication [104].
Given these roles for LRP4 in disorders of the NMJ, ongoing work continues to target the
Agrin-LRP4-MuSK pathway as a potential therapeutic target [105].
An auto-immune mechanism with LRP4 may also function in the motor disorder
amyotrophic lateral sclerosis (ALS), as some ALS patient populations also have LRP4
autoantibodies [31,106]. ALS is a neurodegenerative disorder characterized by progressive
muscle weakness leading to eventual paralysis and death [107]. Some ALS patient popula-
tions are seropositive for LRP4 autoantibodies in both serum and CSF samples, but their
symptoms do not overlap with MG [31,106]. Though implicated, it remains unclear if these
antibodies contribute to disease, and an active question is whether the perturbation of LRP4
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via autoantibodies leads to the denervation of muscle observed in ALS. Moreover, how do
autoantibodies produced in MG and ALS differ, and how do they differentially regulate
LRP4? Given the role for LRP4 in the CNS, it is further possible that autoantibodies against
LRP4 may contribute to upper motor neuron dysfunction, though not understood [106].
Future studies are needed to test the implication of LRP4 in ALS pathogenesis as it may
have a potential role as a therapeutic target.
Finally, emerging roles in CNS function have highlighted a potential role for LRP4 in
Alzheimer’s disease (AD). AD is characterized by lesions in the medial temporal lobe and
cortical areas of the brain, as well as degeneration of neurons and synapses [108], and is
one of the most common causes of dementia. Substantial work on the mechanisms of AD
supports a hypothesis where the accumulation of amyloid-β (Aβ) in the brain contributes
substantially to disease pathology. Aβ is produced by proteolytic cleavage of amyloid
precursor protein (APP). Mutations that interfere with this cause the production of toxic Aβ
that can form pathogenic plaques [108]. APP is regulated in part by ApoE (Apolipoprotein
E), which is in turn regulated by members of the LDLR family [109]. It is this link to APP
that may serve to connect LRP4 in its synaptic role with AD. In motor neurons, LRP4
can bind ApoE to promote neuronal cell viability [110]. During NMJ development, LRP4
and Agrin both interact with APP to promote AChR clustering. It is currently unknown
whether this mechanism may also be present in the CNS [32]. As secreted APP functions
as a ligand for GABAB receptors in regulating synaptic transmission [111] and APP can
function as a Wnt receptor [112], this raises the possibility of a relationship between
synaptic proteins, LRP4, and AD. The mechanistic link, however, remains unknown, as
does how Alzheimer’s progression fits into the established LRP4 functional categories
(though a link to Agrin is strongly possible). A further role is supported by a function
for astrocytic LRP4 in Aβ clearance. Members of the LDLR family including LDLR and
LRP1 are involved in astrocytic clearance of amyloid-β [104,113]. LRP4 also functions in
amyloid-β clearance [33] and is expressed at higher levels in astrocytes than other members
of the LDLR family. In this role, LRP4 promotes Aβ uptake by astrocytes likely by serving
as a receptor for ApoE (as dot blot assays demonstrate that purified LRP4 ectodomain and
human ApoE can physically interact), and therefore may play an important role in response
to AD progression. In mouse models of AD, loss of LRP4 in astrocytes exacerbated disease
pathogenesis [33]. Furthermore, postmortem brain tissue from AD patients exhibited
decreased levels of LRP4 [33]. This body of evidence indicates the potential for LRP4 as
a therapeutic target, and the need for further study of the roles of LRP4 in Alzheimer’s
disease, and the CNS.
7. Conclusions
Once known in the nervous system only as the Agrin receptor at the NMJ, LRP4 has
become a major player in various developmental processes and as an emerging neurode-
generative disease risk gene. As ongoing work demonstrates novel roles for this receptor
in the CNS, its importance has only grown. In its various roles, LRP4 is defined by several
categories of action: functioning at the pre- or postsynapse, with or without Agrin, and in a
cell autonomous or non-cell autonomous manner. The emerging role of LRP4 as a synaptic
organizer in the brain presents fascinating opportunities for future study, and new series of
exciting questions about the nervous system: How does LRP4 instruct synapse formation in
the brain? Does it function via conserved mechanisms in peripheral and central synaptoge-
nesis? Does LRP4 have therapeutic potential in neurodegenerative disorders? These latest
discoveries present new opportunities to understand synapse formation in the brain, the
role of LRP4 in disease, and the conservation of developmental mechanisms. Further work
on LRP4 is necessary to address these questions in our pursuit towards understanding the
nervous system. However, indeed, as the mechanisms for LRP4 function in the CNS are
discovered, future studies will investigate its potential as a therapeutic target in a multitude
of neurological disorders, seeking to connect synaptic function with disease progression.
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